This is primarily attributable to the increase in catabolism-promoting hormones, such as glucocorticoids, glucagon, growth hormones, catecholamine (12), cytokines and other inflammatory mediators, which cause reductions in the glucose uptake and utilization capacities triggered by peripheral insulin, namely insulin resistance (IR). This evidence concerns the gene INS and Insulin resistance.